Metabolomics as a Tool for Discovery – PLOS | ONE article
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age.
Read the Full Publication
Posters & Publications
- Beth Donley and Bob Burrier are excited to be exhibitors at the National @tacanow #Autism Conference in #Atlanta,… https://t.co/Bncq5Ktp1I2 days ago
- Spotlight on our Resources page, full of helpful content for parents. Learn more about how to handle picky eating,… https://t.co/UarRolP5Dq3 days ago
- Sometimes children with #autism act in ways that could be harmful to themselves or others. If a child is secluded o… https://t.co/OJuzLLBwHD3 days ago